id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0575-0044,FDA,FDA-2013-D-0575,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2021-05-19T04:00:00Z,2021,5,2021-05-19T04:00:00Z,,2021-05-19T14:50:03Z,2021-10535,0,0,0900006484b1b4dc
FDA-2013-D-0575-0042,FDA,FDA-2013-D-0575,"Agency Information Collection Activities; Submission for Office of Management and Budget Review;
Comment Request; Expedited Programs for Serious Conditions — Drugs and Biologics",Notice,30 Day Proposed Information Collection,2021-02-18T05:00:00Z,2021,2,2021-02-18T05:00:00Z,2021-03-23T03:59:59Z,2021-02-18T15:19:49Z,2021-03244,0,0,0900006484a3c6c3